The proximal STAT6 and NF-κB sites are responsible for IL-13- and TNF-α-induced RhoA transcriptions in human bronchial smooth muscle cells

Pharmacological Research

Volumn 61, Issue 5, 2010, Pages 466-472

  Goto, Kumiko ^a   Chiba, Yoshihiko ^a   Matsusue, Kimihiko ^b,c   Hattori, Yoshiyuki ^a   Maitani, Yoshie ^a   Sakai, Hiroyasu ^a   Kimura, Shioko ^c   Misawa, Miwa ^a  

^a HOSHI UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Airway hyperresponsiveness; IL 13; NF B; RhoA; STAT6; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; LUCIFERASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING SITE; BRONCHUS MUSCLE; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; BRONCHI; GENE EXPRESSION; HUMANS; INTERLEUKIN-13; LUCIFERASES; MUSCLE, SMOOTH; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PLASMIDS; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; STAT6 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 77950629897     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.12.001     Document Type: Article

References (46)

1. 2+ availability involved in antigen-induced airway hyperresponsiveness in rats. Eur J Pharmacol 1995, 278:79-82.
2. 2+-sensitization of coronary artery contraction in genetically hypertensive rats. Evidence for altered signal transduction in the coronary smooth muscle cells. J Clin Invest 1994, 944:1397-1403.
3. 2+ sensitization of skinned muscle of guinea pig vas deferens. J Pharmacol Exp Ther 1995, 274:555-561.
4. Bremerich D.H., Warner D.O., Lorenz R.R., Shumway R., Jones K.A. Role of protein kinase C in calcium sensitization during muscarinic stimulation in airway smooth muscle. Am J Physiol 1997, 273:L775-781.
5. Chiba Y., Takeyama H., Sakai H., Misawa M. Effects of Y-27632 on acetylcholine-induced contraction of intact and permeabilized intrapulmonary bronchial smooth muscles in rats. Eur J Pharmacol 2001, 427:77-82.
6. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003, 83:1325-1358.
7. Chiba Y., Sakai H., Wachi H., Sugitani H., Seyama Y., Misawa M. Upregulation of RhoA mRNA in bronchial smooth muscle of antigen-induced airway hyperresponsive rats. J Smooth Muscle Res 2003, 39:221-228.
8. Chiba Y., Nakazawa S., Todoroki M., Shinozaki K., Sakai H., Misawa M. Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein. Am J Respir Cell Mol Biol 2009, 40:159-167.
9. Mukai Y., Shimokawa H., Matoba T., Kandabashi T., Satoh S., Hiroki J., et al. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J 2001, 15:1062-1064.
10. Seko T., Ito M., Kureishi Y., Okamoto R., Moriki N., Onishi K., et al. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 2003, 92:411-418.
11. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389:990-994.
12. Shimokawa H., Seto M., Katsumata N., Amano M., Kozai T., Yamawaki T., et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res 1999, 43:1029-1039.
13. Kandabashi T., Shimokawa H., Miyata K., Kunihiro I., Kawano Y., Fukata Y., et al. Inhibition of myosin phosphatase by upregulated Rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation 2000, 101:1319-1323.
14. Chrissobolis S., Sobey C.G. Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: comparison with protein kinase C. Circ Res 2001, 88:774-779.
15. Sato M., Tani E., Fujikawa H., Kaibuchi K. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 2000, 87:195-200.
16. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Curr Allergy Asthma Rep 2004, 4:123-131.
17. Berry M.A., Parker D., Neale N., Woodman L., Morgan A., Monk P., et al. Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J Allergy Clin Immunol 2004, 114:1106-1109.
18. Noah T.L., Tudor G.E., Ivins S.S., Murphy P.C., Peden D.B., Henderson F.W. Repeated measurement of nasal lavage fluid chemokines in school-age children with asthma. Ann Allergy Asthma Immunol 2006, 96:304-310.
19. Prieto J., Lensmar C., Roquet A., van der Ploeg I., Gigliotti D., Eklund A., et al. Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med 2000, 94:806-814.
20. Batra V., Musani A.I., Hastie A.T., Khurana S., Carpenter K.A., Zangrilli J.G., et al. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 2004, 34:437-444.
21. Grunstein M.M., Hakonarson H., Leiter J., Chen M., Whelan R., Grunstein J.S., et al. IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am J Physiol 2002, 282:L520-528.
22. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999, 103:779-788.
23. Kuperman D.A., Huang X., Koth L.L., Chang G.H., Dolganov G.M., Zhu Z., et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 2002, 8:885-889.
24. Laporte J.C., Moore P.E., Baraldo S., Jouvin M.H., Church T.L., Schwartzman I.N., et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 2001, 164:141-148.
25. Shah A., Church M.K., Holgate S.T. Tumour necrosis factor alpha: a potential mediator of asthma. Clin Exp Allergy 1995, 25:1038-1044.
26. Broide D.H., Lotz M., Cuomo A.J., Coburn D.A., Federman E.C., Wasserman S.I. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992, 89:958-967.
27. Taki F., Kondoh Y., Matsumoto K., Takagi K., Satake T., Taniguchi H., et al. Tumor necrosis factor in sputa of patients with bronchial asthma on exacerbation. Arerugi 1991, 40:643-646.
28. Watson M.L., Smith D., Bourne A.D., Thompson R.C., Westwick J. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 1993, 8:365-369.
29. Lukacs N.W., Strieter R.M., Chensue S.W., Widmer M., Kunkel S.L. TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation. J Immunol 1995, 154:5411-5417.
30. Amrani Y., Chen H., Panettieri R.A. Activation of tumor necrosis factor receptor 1 in airway smooth muscle: a potential pathway that modulates bronchial hyper-responsiveness in asthma?. Respir Res 2000, 1:49-53.
31. Sakai H., Otogoto S., Chiba Y., Abe K., Misawa M. Involvement of p42/44 MAPK and RhoA protein in augmentation of ACh-induced bronchial smooth muscle contraction by TNF-alpha in rats. J Appl Physiol 2004, 97:2154-2159.
32. Pennings H.J., Kramer K., Bast A., Buurman W.A., Wouters E.F. Tumour necrosis factor-alpha induces hyperreactivity in tracheal smooth muscle of the guinea-pig in vitro. Eur Respir J 1998, 12:45-49.
33. 2 activation. J Allergy Clin Immunol 2005, 116:537-543.
34. Chiba Y., Tanabe M., Goto K., Sakai H., Misawa M. Downregulation of miR-133a contributes to upregulation of RhoA in bronchial smooth muscle cells. Am J Respir Crit Care Med 2009, 180:713-719.
35. Nagashima S., Yokota M., Nakai E., Kuromitsu S., Ohga K., Takeuchi M., et al. Synthesis and evaluation of 2-{[2-(4-hydroxyphenyl)-ethyl]amino}pyrimidine-5-carboxamide derivatives as novel STAT6 inhibitors. Bioorg Med Chem 2007, 15:1044-1055.
36. Goto K., Chiba Y., Misawa M. IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells. Cytokine 2009, 46:96-99.
37. Goto K., Chiba Y., Sakai H., Misawa M. Tumor necrosis factor-alpha (TNF-alpha) induces upregulation of RhoA via NF-kappaB activation in cultured human bronchial smooth muscle cells. J Pharmacol Sci 2009, 110:437-444.
38. Amrani Y., Panettieri R.A. Modulation of calcium homeostasis as a mechanism for altering smooth muscle responsiveness in asthma. Curr Opin Allergy Clin Immunol 2002, 2:39-45.
39. Chiba Y., Ueno A., Sakai H., Misawa M. Hyperresponsiveness of bronchial but not tracheal smooth muscle in a murine model of allergic bronchial asthma. Inflamm Res 2004, 53:636-642.
40. 2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats. Br J Pharmacol 1999, 127:597-600.
41. 2+ sensitization of bronchial smooth muscle contraction in airway hyperresponsiveness. J Smooth Muscle Res 2004, 40:155-167.
42. 2+ sensitization. Am J Respir Cell Mol Biol 1999, 20:1190-1200.
43. Gosens R., Schaafsma D., Nelemans S.A., Halayko A.J. Rho-kinase as a drug target for the treatment of airway hyperrespon-siveness in asthma. Mini Rev Med Chem 2006, 6:339-348.
44. Hoeck J., Woisetschlager M. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts. J Immunol 2001, 166:4507-4515.
45. Matsukura S., Stellato C., Georas S.N., Casolaro V., Plitt J.R., Miura K., et al. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am J Respir Cell Mol Biol 2001, 24:755-761.
46. Sauzeau V., Rolli-Derkinderen M., Marionneau C., Loirand G., Pacaud P. Rhoa expression is controlled by nitric oxide through cGMP-dependent protein kinase activation. J Biol Chem 2003, 278:9472-9480.